Climb Bio, Inc. (CLYM)
8.87
-0.46
(-4.93%)
USD |
NASDAQ |
Nov 05, 16:00
9.03
+0.16
(+1.80%)
After-Hours: 07:21
Climb Bio SG&A Expense (TTM) : 22.86M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.86M |
| March 31, 2026 | 21.32M |
| December 31, 2025 | 21.17M |
| September 30, 2025 | 20.56M |
| June 30, 2025 | 20.24M |
| March 31, 2025 | 19.80M |
| December 31, 2024 | 16.02M |
| September 30, 2024 | 13.07M |
| June 30, 2024 | 9.701M |
| March 31, 2024 | 9.06M |
| December 31, 2023 | 24.86M |
| September 30, 2023 | 27.50M |
| June 30, 2023 | 29.86M |
| Date | Value |
|---|---|
| March 31, 2023 | 31.77M |
| December 31, 2022 | 18.92M |
| September 30, 2022 | 18.12M |
| June 30, 2022 | 17.02M |
| March 31, 2022 | 15.00M |
| December 31, 2021 | 12.35M |
| September 30, 2021 | 8.526M |
| June 30, 2021 | 5.38M |
| March 31, 2021 | 2.794M |
| September 30, 2020 | 0.576M |
| June 30, 2020 | 0.576M |
| March 31, 2020 | 0.328M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Korsana Biosciences, Inc. | 7.127M |
| Cullinan Therapeutics, Inc. | 50.33M |
| Q32 Bio, Inc. | 13.91M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |
| Oncolytics Biotech, Inc. | 16.62M |